“Biosimilars are an excellent opportunity to have good, valid drug options that improve the sustainability and affordability of cancer treatment in various countries,” said Professor Josep Tabernero, Chair of the ESMO Cancer Medicines Working Group, from the Vall d’Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Spain. “To do that we […]

Researchers at Mayo Clinic in Jacksonville, Fla., are reporting they have discovered genetic evidence that guanine nucleotide exchange factor (GEF) epithelial cell transforming sequence 2 (Ect2) drives lung adenocarcinoma tumor formation. The researchers note that Ect2 in the past has been associated with cancer. However, this paper demonstrates for the first time that Ect2 is […]